XB
X1 Biotech Inc.
SEC filingOther Technology · Needham, MA
Amount raised$40Ksold at filing
Total offering$2M$2M still open
Investors in the raise2count reported to the SEC
FiledJun 15, 2026first sale May 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Lawrence KaufmanExecutive Officer
Joseph Arboleda-VelasquezDirector
Leo KimDirector
Michael AcetiExecutive Officer
Dean EliottDirector
Neal ChenDirector
Executive officers, directors and promoters as listed on the Form D.